Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 11-Mar-24 4:42 PM View:  | Knell Michael Gunnar CSVP&Chief Accounting Officer | Charles River Laboratories ... (CRL) | 08-Mar-24 | Private Sale | 808 | $267.52 | $216,156.00 | (10%) 7.83K to 7.02K | |
| 05-Mar-24 4:54 PM View: | Knell Michael Gunnar CSVP&Chief Accounting Officer | Charles River Laboratories ... (CRL) | 04-Mar-24 | Private Sale | 2,750 | $261.05 | $717,890.00 | (26%) 10.58K to 7.83K | |
| 04-Mar-24 4:09 PM View: | Parisotto Shannon M CEVP, Disc & Safety Assessment | Charles River Laboratories ... (CRL) | 01-Mar-24 | Gift | 412 | -- | -- | (1%) 34.1K to 33.69K | |
| 01-Mar-24 5:37 PM View: | Creamer Victoria L EVP & Chief People Officer | Charles River Laboratories ... (CRL) | 29-Feb-24 | Private Sale | 5,000 | $253.70 | $1,268,500.00 | (27%) 18.55K to 13.55K | |
| 04-Mar-24 4:09 PM View: | Parisotto Shannon M CEVP, Disc & Safety Assessment | Charles River Laboratories ... (CRL) | 29-Feb-24 | Private Sale | 3,786 | $253.45 | $959,545.00 | (10%) 37.88K to 34.1K | |
| 23-Feb-24 4:57 PM View: | Barbo William D Corporate Executive VP & CCO | Charles River Laboratories ... (CRL) | 22-Feb-24 | Private Sale | 4,050 | $248.50 | $1,006,420.00 | (13%) 30.96K to 26.91K | |
| 20-Feb-24 5:28 PM View: | Foster James C Chairman, President and CEO Director | Charles River Laboratories ... (CRL) | 16-Feb-24 | Gift | 4,000 | -- | -- | (1%) 268.44K to 264.44K | |
| 20-Feb-24 5:32 PM View: | Parisotto Shannon M CEVP, Disc & Safety Assessment | Charles River Laboratories ... (CRL) | 15-Feb-24 | Option Exercise | 5,882 | $144.67 | $850,949.00 | 16% 37.88K to 43.77K | (9%) |
| 20-Feb-24 5:32 PM View: | Parisotto Shannon M CEVP, Disc & Safety Assessment | Charles River Laboratories ... (CRL) | 15-Feb-24 | Private Option Sale | 5,882 | $241.21 | $1,418,770.00 | (13%) 43.77K to 37.88K | |
| 16-Feb-24 6:37 PM View: | Girshick Birgit Corporate Executive VP & COO | Charles River Laboratories ... (CRL) | 15-Feb-24 | Gift | 424 | -- | -- | (< 1%) 48.12K to 47.69K | |
| 20-Feb-24 5:20 PM View: | Laplume Joseph W EVP, Corp Strategy & Develop | Charles River Laboratories ... (CRL) | 15-Feb-24 | Private Sale | 838 | $238.93 | $200,223.00 | (3%) 25.46K to 24.62K | |
| 05-Feb-24 8:31 PM View: | Kemps-Polanco Reshema Director | Charles River Laboratories ... (CRL) | 01-Feb-24 | Grant | 170 | -- | -- | 100% 0 to 0.17K | |
| 31-Jan-24 5:03 PM View: | Foster James C Chairman, President and CEO Director | Charles River Laboratories ... (CRL) | 29-Jan-24 | Grant | 24,253 | -- | -- | 10% 254.95K to 279.2K | |
| 31-Jan-24 7:35 PM View: | Parisotto Shannon M CEVP, Disc & Safety Assessment | Charles River Laboratories ... (CRL) | 29-Jan-24 | Grant | 2,115 | -- | -- | 6% 36.32K to 38.44K | |
| 31-Jan-24 5:28 PM View: | Laplume Joseph W EVP, Corp Strategy & Develop | Charles River Laboratories ... (CRL) | 29-Jan-24 | Grant | 3,350 | -- | -- | 14% 23.13K to 26.48K | |
| 31-Jan-24 5:31 PM View: | Knell Michael Gunnar CSVP&Chief Accounting Officer | Charles River Laboratories ... (CRL) | 29-Jan-24 | Grant | 968 | -- | -- | 10% 9.94K to 10.91K | |
| 31-Jan-24 7:14 PM View: | Girshick Birgit Corporate Executive VP & COO | Charles River Laboratories ... (CRL) | 29-Jan-24 | Payment of Exercise | 1,159 | $220.28 | $255,305.00 | (2%) 49.27K to 48.12K | |
| 31-Jan-24 4:59 PM View: | Foster James C Chairman, President and CEO Director | Charles River Laboratories ... (CRL) | 29-Jan-24 | Payment of Exercise | 12,710 | $224.56 | $2,854,160.00 | (5%) 267.66K to 254.95K | |
| 31-Jan-24 4:59 PM View: | Foster James C Chairman, President and CEO Director | Charles River Laboratories ... (CRL) | 29-Jan-24 | Option Exercise | 17,436 | $144.67 | $2,522,470.00 | 7% 250.22K to 267.66K | (9%) |
| 31-Jan-24 7:35 PM View: | Parisotto Shannon M CEVP, Disc & Safety Assessment | Charles River Laboratories ... (CRL) | 29-Jan-24 | Payment of Exercise | 555 | $220.28 | $122,255.00 | (1%) 38.44K to 37.88K | |
| 31-Jan-24 5:28 PM View: | Laplume Joseph W EVP, Corp Strategy & Develop | Charles River Laboratories ... (CRL) | 29-Jan-24 | Payment of Exercise | 1,025 | $220.28 | $225,787.00 | (4%) 26.48K to 25.46K | |
| 31-Jan-24 5:31 PM View: | Knell Michael Gunnar CSVP&Chief Accounting Officer | Charles River Laboratories ... (CRL) | 29-Jan-24 | Payment of Exercise | 326 | $220.28 | $71,811.30 | (3%) 10.91K to 10.58K | |
| 31-Jan-24 5:26 PM View: | Creamer Victoria L EVP & Chief People Officer | Charles River Laboratories ... (CRL) | 29-Jan-24 | Grant | 2,997 | -- | -- | 18% 16.51K to 19.5K | |
| 31-Jan-24 5:23 PM View: | Barbo William D Corporate Executive VP & CCO | Charles River Laboratories ... (CRL) | 29-Jan-24 | Grant | 2,997 | -- | -- | 10% 28.74K to 31.73K | |
| 31-Jan-24 5:03 PM View: | Foster James C Chairman, President and CEO Director | Charles River Laboratories ... (CRL) | 29-Jan-24 | Payment of Exercise | 10,757 | $220.28 | $2,369,550.00 | (4%) 279.2K to 268.44K | |
| 31-Jan-24 5:26 PM View: | Creamer Victoria L EVP & Chief People Officer | Charles River Laboratories ... (CRL) | 29-Jan-24 | Payment of Exercise | 953 | $220.28 | $209,927.00 | (5%) 19.5K to 18.55K | |
| 31-Jan-24 7:14 PM View: | Girshick Birgit Corporate Executive VP & COO | Charles River Laboratories ... (CRL) | 29-Jan-24 | Grant | 3,526 | -- | -- | 8% 45.75K to 49.27K | |
| 31-Jan-24 5:23 PM View: | Barbo William D Corporate Executive VP & CCO | Charles River Laboratories ... (CRL) | 29-Jan-24 | Payment of Exercise | 770 | $220.28 | $169,616.00 | (2%) 31.73K to 30.96K | |
| 11-Jan-24 4:09 PM View: | Girshick Birgit Corporate Executive VP & COO | Charles River Laboratories ... (CRL) | 10-Jan-24 | Option Exercise | 5,916 | $215.19 | $1,273,060.00 | 13% 44.45K to 50.37K | |
| 11-Jan-24 4:09 PM View: | Girshick Birgit Corporate Executive VP & COO | Charles River Laboratories ... (CRL) | 10-Jan-24 | Payment of Exercise | 4,590 | $215.19 | $987,722.00 | (9%) 50.37K to 45.77K | |
| 18-Dec-23 4:07 PM View: | Creamer Victoria L EVP & Chief People Officer | Charles River Laboratories ... (CRL) | 14-Dec-23 | Planned Private Option Sale | 5,526 | $225.00 | $1,243,350.00 | (25%) 22.03K to 16.51K | |
| 18-Dec-23 4:07 PM View: | Creamer Victoria L EVP & Chief People Officer | Charles River Laboratories ... (CRL) | 14-Dec-23 | Option Exercise | 5,526 | $136.70 | $755,388.00 | 33% 16.51K to 22.03K | (3%) |
| 01-Dec-23 4:10 PM View: | Laplume Joseph W EVP, Corp Strategy & Develop | Charles River Laboratories ... (CRL) | 30-Nov-23 | Private Sale | 1,850 | $197.73 | $365,800.00 | (7%) 24.98K to 23.13K | |
| 21-Nov-23 5:07 PM View: | Girshick Birgit Corporate Executive VP & COO | Charles River Laboratories ... (CRL) | 20-Nov-23 | Purchase | 1,322 | $187.82 | $248,298.00 | 3% 43.13K to 44.45K | |
| 15-Nov-23 9:23 AM View: | Foster James C Chairman, President and CEO Director | Charles River Laboratories ... (CRL) | 14-Nov-23 | Purchase | 5,620 | $178.05 | $1,000,640.00 | 2% 244.6K to 250.22K | |
| 13-Nov-23 4:12 PM View: | Laplume Joseph W EVP, Corp Strategy & Develop | Charles River Laboratories ... (CRL) | 09-Nov-23 | Option Exercise | 9,128 | $144.67 | $1,320,550.00 | 37% 24.98K to 34.11K | (9%) |
| 13-Nov-23 4:12 PM View: | Laplume Joseph W EVP, Corp Strategy & Develop | Charles River Laboratories ... (CRL) | 09-Nov-23 | Private Option Sale | 9,128 | $173.48 | $1,583,520.00 | (27%) 34.11K to 24.98K | |
| 29-Aug-23 4:23 PM View: | Wallman Richard F Director | Charles River Laboratories ... (CRL) | 24-Aug-23 | Purchase | 1,000 | $198.79 | $198,786.00 | 4% 22.53K to 23.53K | |
| 14-Aug-23 4:17 PM View: | Barbo William D Corporate Executive VP & CCO | Charles River Laboratories ... (CRL) | 10-Aug-23 | Sale | 252 | $217.24 | $54,744.50 | (< 1%) 28.99K to 28.74K | |
| 14-Aug-23 4:13 PM View: | Foster James C Chairman, President and CEO Director | Charles River Laboratories ... (CRL) | 10-Aug-23 | Gift | 2,500 | -- | -- | (1%) 247.1K to 244.6K | |
| 14-Aug-23 4:15 PM View: | Knell Michael Gunnar CSVP&Chief Accounting Officer | Charles River Laboratories ... (CRL) | 10-Aug-23 | Option Exercise | 1,471 | $144.67 | $212,810.00 | 15% 9.94K to 11.41K | (9%) |
| 14-Aug-23 4:17 PM View: | Barbo William D Corporate Executive VP & CCO | Charles River Laboratories ... (CRL) | 10-Aug-23 | Option Exercise | 5,511 | $144.67 | $797,276.00 | 19% 28.99K to 34.5K | (9%) |
| 14-Aug-23 4:11 PM View: | Laplume Joseph W EVP, Corp Strategy & Develop | Charles River Laboratories ... (CRL) | 10-Aug-23 | Private Sale | 700 | $216.52 | $151,564.00 | (3%) 25.68K to 24.98K | |
| 14-Aug-23 4:15 PM View: | Knell Michael Gunnar CSVP&Chief Accounting Officer | Charles River Laboratories ... (CRL) | 10-Aug-23 | Private Option Sale | 1,471 | $216.54 | $318,530.00 | (13%) 11.41K to 9.94K | |
| 14-Aug-23 4:17 PM View: | Barbo William D Corporate Executive VP & CCO | Charles River Laboratories ... (CRL) | 10-Aug-23 | Private Option Sale | 5,511 | $217.24 | $1,197,210.00 | (16%) 34.5K to 28.99K | |
| 05-Jul-23 3:29 PM View: | MacKay Martin Director | Charles River Laboratories ... (CRL) | 03-Jul-23 | Grant | 95 | -- | -- | < 1% 11.51K to 11.6K | |
| 02-Jun-23 3:31 PM View: | Knell Michael Gunnar CSVP&Chief Accounting Officer | Charles River Laboratories ... (CRL) | 01-Jun-23 | Grant | 1,528 | -- | -- | 18% 8.41K to 9.94K | |
| 02-Jun-23 10:22 AM View: | MacKay Martin Director | Charles River Laboratories ... (CRL) | 31-May-23 | Grant | 338 | -- | -- | 3% 11.17K to 11.51K | |
| 31-May-23 4:17 PM View: | Knell Michael Gunnar CSVP&Chief Accounting Officer | Charles River Laboratories ... (CRL) | 29-May-23 | Payment of Exercise | 36 | $194.12 | $6,988.32 | (< 1%) 8.45K to 8.41K | |
| 31-May-23 1:27 PM View: | Barbo William D Corporate Executive VP & CCO | Charles River Laboratories ... (CRL) | 29-May-23 | Payment of Exercise | 202 | $194.12 | $39,212.20 | (2%) 10.16K to 9.95K |
